Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
5
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
fda
deals
investing
national top stories
480 biomedical
ally bridge group
arsenal medical
big data analytics
biofourmis
biotech ipos
biovotion
blackrock
bob langer
cancer
casdin capital
chronic rhinosinusitis
chugai pharmaceutical
codiak biosciences
covid-19
cutaneous t-cell lymphoma
diabetic nephropathy
drug delivery
dyne therapeutics
edbi
eventide asset management
exosome
focal segmental glomerulosclerosis
gaido health
genzyme
george whitesides
goldfinch bio
inflammation
ipo
What
million
5
×
ipo
raised
company
medicines
new
therapeutics
biotech
brings
developing
drug
genetic
raises
tests
treat
analysis
analytics
based
begin
bio
biofourmis
biosciences
bio’s
bring
bubbles
cells
class
clinical
codiak
data
debut
develop
devices
digital
diseases
disorders
dyne
dyne’s
employing
employs
Language
unset
5
×
Current search:
boston
×
million
×
unset
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses